Bibliographic Info
GuidelineWHO guidelines for malaria, 3 June 2022.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Low
Mass drug administration (MDA) for burden reduction: Antimalarial medicine can be given as chemoprevention through mass drug administration (MDA) in areas of moderate to high transmission of P. falciparum to provide short-term reductions in disease burden.
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO guidelines for malaria, 25 November 2022.
Year2022
InstitutionWorld Health Organization
Guideline
WHO guidelines for malaria, 16 October 2023.
Year2023
InstitutionWorld Health Organization
Guideline
WHO Guidelines for malaria, 14 March 2023
Year2023
InstitutionWHO
Guideline
WHO guidelines for malaria, 30 November 2024.
Year2024
InstitutionWHO